Pfizer CEO Albert Bourla Anticipates Two Years of Patent-Related Challenges, Focuses on Acquisitions and Pipeline Expansion
Trendline

Pfizer CEO Albert Bourla Anticipates Two Years of Patent-Related Challenges, Focuses on Acquisitions and Pipeline Expansion

What's Happening? Pfizer CEO Albert Bourla announced on November 17 that the company expects to face challenges for the next two years due to the loss of exclusive rights for some of its products. Despite these anticipated patent-related burdens, Bourla outlined a strategy for growth centered on acq
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.